Trial intelligence / Profile preview

Axiron in Hypogonadal Men with Suboptimal Response to Gel

NCT01893281Phase 4Completed

Sponsor
Eli Lilly and Company
Start
Jul 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of testosterone topical solution in Hypogonadism, sponsored by Eli Lilly and Company. Started Jul 2013; status: completed.

02

Drugs

testosterone topical solution
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT01893281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01893281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call